Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia
| dc.contributor.author | McCubrey, James A. | |
| dc.date.accessioned | 2022-01-31T19:21:46Z | |
| dc.date.available | 2022-01-31T19:21:46Z | |
| dc.date.issued | 2016-08-23 | |
| dc.identifier.doi | 10.18632/oncotarget.10984 | |
| dc.identifier.issn | 1949-2553 | |
| dc.identifier.uri | http://hdl.handle.net/10342/9592 | |
| dc.language.iso | en_US | en_US |
| dc.subject | T lymphocytes | en_US |
| dc.subject | PI3K/Akt/mTOR signaling | en_US |
| dc.subject | T-acute lymphoblastic leukemia | en_US |
| dc.title | Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia | en_US |
| dc.type | Article | en_US |
| ecu.journal.issue | 34 | en_US |
| ecu.journal.name | Oncotarget | en_US |
| ecu.journal.volume | 7 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- McCubreyHealthyCD4TLymphocytesarenotaffectedbytargetedtherapies.pdf
- Size:
- 2.49 MB
- Format:
- Adobe Portable Document Format
- Description:
- Article